#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13936	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2454	697.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1644	1644	C	890	C,T	889,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24260	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	751.3	0	.	n	.	0	T695C	SNP	695	695	T	1221	1221	C	940	C,A,T,G	935,3,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24260	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	751.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1863	1863	A	981	A,G,C	979,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24260	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	751.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2497	2497	C	885	C,A	884,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24260	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	751.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2571	2571	A	793	A,G	791,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24260	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4019	751.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3123	3123	C	843	C,G,T	840,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	R7Q	NONSYN	19	21	CGG	615	617	CAG	127;126;126	C,A;A,T;G	126,1;125,1;126	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	E12K	NONSYN	34	36	GAA	630	632	AAA	138;136;139	A,T;A;A,G	136,2;136;138,1	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	F31L	NONSYN	91	93	TTT	687	689	TTG	178;176;177	T;T;G	178;176;177	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	S68P	NONSYN	202	204	TCG	798	800	CCG	181;180;179	C;C,G;G	181;179,1;179	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	F72Y	NONSYN	214	216	TTC	810	812	TAT	184;182;181	T;A;T	184;182;181	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	P74S	NONSYN	220	222	CCG	816	818	TCG	181;180;180	T;C,A;G,T	181;179,1;179,1	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	A89V	NONSYN	265	267	GCG	861	863	GTG	157;155;151	G,C;T;G	156,1;155;151	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	V130L	NONSYN	388	390	GTC	984	986	CTC	184;187;187	C;T;C	184;187;187	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	R135C	NONSYN	403	405	CGC	999	1001	TGT	193;193;192	T;G;T	193;193;192	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	R147Q	NONSYN	439	441	CGG	1035	1037	CAG	217;219;218	C,A;A;G	216,1;219;218	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1047	1049	AAG	216;216;215	A;A;G,T	216;216;214,1	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	1050	1052	AAT	215;217;218	A;A;T	215;217;218	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	D155I	NONSYN	463	465	GAC	1059	1061	ATT	220;219;215	A;T,G;T	220;218,1;215	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	T172A	NONSYN	514	516	ACA	1110	1112	GCG	193;193;194	G;C,T;G	193;192,1;194	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	S174A	NONSYN	520	522	TCA	1116	1118	GCG	197;197;200	G,T;C;G	196,1;197;200	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	E175A	NONSYN	523	525	GAA	1119	1121	GCG	200;200;205	G;C;G	200;200;205	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	T176E	NONSYN	526	528	ACC	1122	1124	GAA	205;204;204	G,T;A;A	204,1;204;204	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	V178I	NONSYN	532	534	GTC	1128	1130	ATC	203;203;205	A,G;T;C	202,1;203;205	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	1454	folP	852	852	91.68	folP.l6.c4.ctg.1	1836	98.5	0	.	p	.	0	K197fs	FSHIFT	589	589	A	1185	1185	A	168	A	168	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	4059	166.3	1	SNP	p	S91F	0	.	.	271	273	TCC	905	907	TCC	201;200;199	T,G,A;C,T;C,T	198,1,1;199,1;198,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	4059	166.3	1	SNP	p	D95N	0	.	.	283	285	GAC	917	919	GAC	214;214;215	G;A,C;C	214;213,1;215	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5416	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	4059	166.3	1	SNP	p	D95G	0	.	.	283	285	GAC	917	919	GAC	214;214;215	G;A,C;C	214;213,1;215	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1756	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1841	118.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	791	793	ACC	174;176;176	A,C;C;C,A	173,1;176;175,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1756	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1841	118.7	0	.	p	.	0	R44H	NONSYN	130	132	CGC	806	808	CAC	174;173;173	C;A;C,T	174;173;172,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1756	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1841	118.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	989	991	CAC	224;228;228	C,T,G;A;C,A	222,1,1;228;227,1	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1756	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1841	118.7	1	SNP	p	G45D	0	.	.	133	135	GGC	809	811	GGC	173;174;178	G,C;G,A;C	172,1;173,1;178	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1048	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1473	88.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5100	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3300	192.1	1	SNP	p	D86N	0	.	.	256	258	GAC	744	746	GAC	223;223;220	G,T,A;A,T;C,T	221,1,1;222,1;219,1	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5100	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3300	192.1	1	SNP	p	S87R	0	.	.	259	261	AGT	747	749	AGT	220;223;223	A,C;G;T	219,1;223;223	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5100	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3300	192.1	1	SNP	p	S87W	0	.	.	259	261	AGT	747	749	AGT	220;223;223	A,C;G;T	219,1;223;223	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5100	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3300	192.1	1	SNP	p	S87I	0	.	.	259	261	AGT	747	749	AGT	220;223;223	A,C;G;T	219,1;223;223	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5100	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3300	192.1	1	SNP	p	S88P	0	.	.	262	264	TCC	750	752	TCC	226;226;227	T;C;C	226;226;227	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4152	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3265	158.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1872	1874	GGC	224;224;223	G,A;G;C,T	223,1;224;222,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1492	1494	GCA	235;237;235	G;C;A	235;237;235	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1495	1497	ATC	233;230;233	A;T;C	233;230;233	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1507	1509	GTG	226;228;230	G;T;G	226;227;230	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1507	1509	GTG	226;228;230	G;T;G	226;227;230	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2011	2013	ACC	212;212;212	A;C,A;C	212;211,1;212	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2065	2067	GCG	193;191;193	G,C;C;G	192,1;191;193	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2065	2067	GCG	193;191;193	G,C;C;G	192,1;191;193	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2188	2190	GGC	205;204;205	G;G,C;C	205;203,1;205	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2197	2199	GGC	203;205;205	G;G;C	202;205;205	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3792	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2904	162.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2215	2217	CCG	215;218;215	C,G;C;GCCC,GCC	214,1;218;209,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5540	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3663	188.4	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1903	1905	CTG	219;223;221	C;T;G	219;223;221	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2520	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2403	130.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	858	858	C	192	C	192	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	S271T	NONSYN	811	813	TCG	110	112	ACT	66;66;66	A;C;T,C	66;66;65,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	116	118	GAT	66;66;66	G;A;T,C	66;66;65,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	119	121	AGT	66;66;66	A;G,C;T	66;65,1;66	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	N277H	NONSYN	829	831	AAC	128	130	CAC	65;65;65	C;A;C	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	R307E	NONSYN	919	921	AGA	218	220	GAA	4;4;4	G;A;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	230	232	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	233	235	GAC	4;4;4	G;A;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	239	241	ATC	4;4;4	A;T;C	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	245	247	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	251	253	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	254	256	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	257	259	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	302	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	403	28.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	263	265	GTT	4;4;5	G;T;T	4;4;5	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	G38E	NONSYN	112	114	GGA	555	557	GAA	209;210;210	G;A;A	209;210;210	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	S46G	NONSYN	136	138	AGC	579	581	GGC	207;207;207	G;G;C	207;207;207	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	E48G	NONSYN	142	144	GAA	585	587	GGA	212;213;216	G;G,A;A	212;212,1;216	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	T87A	NONSYN	259	261	ACT	702	704	GCT	205;207;210	G,C;C,A;T	204,1;206,1;210	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	T89S	NONSYN	265	267	ACC	708	710	AGC	205;207;208	A;G;C	205;207;208	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	.	MULTIPLE	358	359	AA	800	801	CG	192;191	C,T;G	191,1;191	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	.	MULTIPLE	361	362	GA	803	805	CAG	197;198;197	C;A,T;G	197;197,1;197	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	N122K	NONSYN	364	366	AAC	807	809	AAA	196;194;195	A,G;A;A	195,1;194;195	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	K143E	NONSYN	427	429	AAA	870	872	GAA	186;187;186	G;A;A	186;187;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	V151A	NONSYN	451	453	GTA	894	896	GCA	204;205;204	G;C,T;A	204;204,1;204	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	A215T	NONSYN	643	645	GCT	1086	1088	ACT	206;204;201	A;C,G;T	206;202,1;200	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1095	1097	ATG	207;208;202	A;T;G	207;208;202	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1209	1211	GCA	230;229;228	G;C;A	230;229;228	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1212	1214	ACG	229;229;233	A;C;G	229;228;232	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1215	1217	GGG	232;228;228	G;G;G	231;227;227	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1218	1220	GTT	226;219;217	G,C,A;T;T,G	223,1,1;219;216,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1278	1280	GTA	206;206;205	G,A;T,G;A	205,1;205,1;205	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1317	1319	ACT	200;197;197	A;C;T,C	200;197;196,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1323	1325	GAT	202;204;207	G;A;T,C	202;204;206,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1335	1337	CAC	210;210;214	C;A;C	210;210;214	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	1	SNP	p	G120K	1	.	.	358	360	AAG	800	802	CGG	192;191;195	C,T;G;G	191,1;191;195	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	1	SNP	p	D121N	0	.	.	361	363	GAC	803	806	CGC	197;197;199	C;G;C	197;197;199	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2554	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1795	175.0	1	SNP	p	A121D	1	.	.	361	363	GAC	803	806	CGC	197;197;199	C;G;C	197;197;199	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9390	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5358	218.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2177	2179	AAT	250;250;248	A;A,C;T,G	250;249,1;247,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1314	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1532	106.9	1	SNP	p	V57M	1	.	.	169	171	ATG	746	748	ATG	234;236;237	A;T;G	234;236;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
